Follow
Sourya Shrestha
Title
Cited by
Cited by
Year
Interactions between serotypes of dengue highlight epidemiological impact of cross-immunity
NG Reich, S Shrestha, AA King, P Rohani, J Lessler, S Kalayanarooj, ...
Journal of The Royal Society Interface 10 (86), 20130414, 2013
3522013
Identifying the interaction between influenza and pneumococcal pneumonia using incidence data
S Shrestha, B Foxman, DM Weinberger, C Steiner, C Viboud, P Rohani
Science translational medicine 5 (191), 191ra84-191ra84, 2013
1672013
Predicting the effect of climate change on African trypanosomiasis: integrating epidemiology with parasite and vector biology
S Moore, S Shrestha, KW Tomlinson, H Vuong
Journal of the Royal Society Interface 9 (70), 817-830, 2012
1492012
The epidemiological importance of subclinical tuberculosis. A critical reappraisal
EA Kendall, S Shrestha, DW Dowdy
American journal of respiratory and critical care medicine 203 (2), 168-174, 2021
972021
The importance of heterogeneity to the epidemiology of tuberculosis
JM Trauer, PJ Dodd, MGM Gomes, GB Gomez, RMGJ Houben, ...
Clinical infectious diseases 69 (1), 159-166, 2019
952019
Statistical inference for multi-pathogen systems
S Shrestha, AA King, P Rohani
PLoS computational biology 7 (8), e1002135, 2011
862011
Evolution of acute infections and the invasion-persistence trade-off
AA King, S Shrestha, ET Harvill, ON Bjørnstad
The American Naturalist 173 (4), 446-455, 2009
652009
The distribution of fitness costs of resistance-conferring mutations is a key determinant for the future burden of drug-resistant tuberculosis: a model-based analysis
GM Knight, C Colijn, S Shrestha, M Fofana, F Cobelens, RG White, ...
Clinical infectious diseases 61 (suppl_3), S147-S154, 2015
622015
The role of influenza in the epidemiology of pneumonia
S Shrestha, B Foxman, J Berus, WG Van Panhuis, C Steiner, C Viboud, ...
Scientific reports 5 (1), 15314, 2015
592015
Spatially targeted screening to reduce tuberculosis transmission in high-incidence settings
PGT Cudahy, JR Andrews, A Bilinski, DW Dowdy, B Mathema, ...
The Lancet Infectious Diseases 19 (3), e89-e95, 2019
512019
Time and dose-dependent risk of pneumococcal pneumonia following influenza: a model for within-host interaction between influenza and Streptococcus pneumoniae
S Shrestha, B Foxman, S Dawid, AE Aiello, BM Davis, J Berus, P Rohani
Journal of the Royal Society interface 10 (86), 20130233, 2013
482013
Influenza and community-acquired pneumonia interactions: the impact of order and time of infection on population patterns
BM Davis, AE Aiello, S Dawid, P Rohani, S Shrestha, B Foxman
American journal of epidemiology 175 (5), 363-367, 2012
322012
Comparing drivers and dynamics of tuberculosis in California, Florida, New York, and Texas
S Shrestha, AN Hill, SM Marks, DW Dowdy
American journal of respiratory and critical care medicine 196 (8), 1050-1059, 2017
312017
Mathematical modelling and tuberculosis: advances in diagnostics and novel therapies
A Zwerling, S Shrestha, DW Dowdy
Advances in medicine 2015, 2015
312015
Model-based cost-effectiveness of state-level latent tuberculosis interventions in California, Florida, New York, and Texas
Y Jo, S Shrestha, I Gomes, S Marks, A Hill, G Asay, D Dowdy
Clinical Infectious Diseases 73 (9), e3476-e3482, 2021
292021
Priority-setting for novel drug regimens to treat tuberculosis: an epidemiologic model
EA Kendall, S Shrestha, T Cohen, E Nuermberger, KE Dooley, ...
PLoS medicine 14 (1), e1002202, 2017
282017
Modelling the impact of social protection on tuberculosis: the S-PROTECT project
D Boccia, W Rudgard, S Shrestha, K Lönnroth, P Eckhoff, J Golub, ...
BMC Public Health 18, 1-9, 2018
272018
A multistrain mathematical model to investigate the role of pyrazinamide in the emergence of extensively drug-resistant tuberculosis
MO Fofana, S Shrestha, GM Knight, T Cohen, RG White, F Cobelens, ...
Antimicrobial agents and chemotherapy 61 (3), 10.1128/aac. 00498-16, 2017
242017
Spotting the old foe—revisiting the case definition for TB
RMGJ Houben, H Esmail, JC Emery, LR Joslyn, CF McQuaid, ...
The Lancet Respiratory Medicine 7 (3), 199-201, 2019
222019
Drivers and trajectories of resistance to new first-line drug regimens for tuberculosis
S Shrestha, GM Knight, M Fofana, T Cohen, RG White, F Cobelens, ...
Open forum infectious diseases 1 (2), ofu073, 2014
222014
The system can't perform the operation now. Try again later.
Articles 1–20